Freed Investment Group »

Pmv Pharmaceuticals shares owned by Freed Investment Group

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by Freed Investment Group from 13F filings

Historical chart of Freed Investment Group investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by Freed Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by Freed Investment Group

Quarter filed Position value Share count Share price at filing
2021-09-30 $741 25k 0.03

More positions owned by Freed Investment Group

Fidelity Comwlth Tr Nasdaq Compsit (ONEQ)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Pmv Pharmaceuticals (PMVP)
NVIDIA Corporation (NVDA)
Johnson & Johnson (JNJ)
Codiak Biosciences
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vir Biotechnology (VIR)

View all positions for Freed Investment Group

Top funds holding Pmv Pharmaceuticals

OrbiMed Advisors
Arrowpoint Asset Management
Sio Capital Management
Euclidean Capital
Alkeon Capital Management
Vanguard Group
Acadian Asset Management
Partner Fund Management
BML Capital Management
BlackRock
Citadel Advisors
D. E. Shaw & Co
Two Sigma Advisers
Jacobs Levy Equity Management
Personal Cfo Solutions

View all funds holding Pmv Pharmaceuticals